Advertisement
Loading...

Edwards Lifesciences Corporation

EW•NYSE
Healthcare
Medical - Devices
$81.38
$0.04(0.05%)
U.S. Market opens in 37h 54m

Edwards Lifesciences Corporation (EW) Stock Overview

Explore Edwards Lifesciences Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap46.9B
P/E Ratio43.06
EPS (TTM)$1.85
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$86.04
3 Months$94.32
1 Year Target$80.09

EW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Edwards Lifesciences Corporation (EW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $80.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 43.06 and a market capitalization of 46.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.04%
5-Day Change
-1.83%
1-Month Change
4.06%
3-Month Change
7.26%
6-Month Change
-5.71%
Year-to-Date (YTD) Change
-4.55%
1-Year Change
5.85%
3-Year Change
-8.49%
5-Year Change
-9.43%
All-Time (Max) Change
5818.18%

Contact Information

https://www.edwards.com
949 250 2500
One Edwards Way, Irvine, CA, 92614

Company Facts

15,800 Employees
IPO DateMar 27, 2000
CountryUS
Actively Trading

Frequently Asked Questions